Erivedge

Product manufactured by Genentech, Inc.

Application Nr Approved Date Route Status External Links
NDA203388 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Erivedge Is Indicated For The Treatment Of Adults With Metastatic Basal Cell Carcinoma, Or With Locally Advanced Basal Cell Carcinoma That Has Recurred Following Surgery Or Who Are Not Candidates For Surgery And Who Are Not Candidates For Radiation. Erivedge ® (Vismodegib) Is A Hedgehog Pathway Inhibitor Indicated For The Treatment Of Adults With Metastatic Basal Cell Carcinoma, Or With Locally Advanced Basal Cell Carcinoma That Has Recurred Following Surgery Or Who Are Not Candidates For Surgery And Who Are Not Candidates For Radiation. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Vismodegib VISMODEGIB ZINC40899447

Comments